Andrew Huberman· PhD
Now, that said, even as these medications exist now, as you know, there's an impulse to use them in very small doses and to use them as adjunctive treatments for the therapy of various kinds. And I'm also supportive of that if done carefully and rigorously, of course there's risk, but there's risk with many other kinds of treatments. And I'm not sure that the risks for these medications vastly outweigh the risks that we normally tolerate in other branches of medicine.